Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: A cohort study

Annals of Internal Medicine

Volumn 153, Issue 5, 2010, Pages 281-288

  Romero Gómez, Manuel ^a   Jover, María ^a   Del Campo, José A ^a   Royo, José L ^b   Hoyas, Elena ^a   Galán, José J ^c   Montoliu, Carmina ^d   Baccaro, Eugenia ^e   Guevara, Mónica ^e   Córdoba, Juan ^f   Soriano, Germán ^g   Navarro, José M ^h   Martínez Sierra, Carmen ⁱ   Grande, Lourdes ^a   Galindo, Antonio ^a   Mira, Emilia ^j   Mañes, Santos ^j   Ruiz, Agustín ^c  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^c Neocodex SL   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^h HOSPITAL COSTA DEL SOL   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^j CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINASE; LUCIFERASE; MICROSATELLITE DNA;

ADULT; ALLELE; ARTICLE; BASE PAIRING; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC TRANSFECTION; GENETIC VARIABILITY; HAPLOTYPE; HAZARD RATIO; HEPATIC ENCEPHALOPATHY; HEREDITY; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; OUTPATIENT DEPARTMENT; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; VALIDATION STUDY; AGED; CLINICAL TRIAL; ENZYMOLOGY; GENETICS; MIDDLE AGED; MULTICENTER STUDY; MUTATION; RISK FACTOR;

AGED; FEMALE; GLUTAMINASE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 77956655411     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-5-201009070-00002     Document Type: Article

References (33)

1. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999;30:890-5. [PMID: 10365817]
2. Hui AY, Chan HL, Leung NW, Hung LC, Chan FK, Sung JJ. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol. 2002;34:569-72. [PMID: 11960072]
3. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology. 2002;36:1163-71. [PMID: 12395326]
4. Weber FL Jr, Veach GL. The importance of the small intestine in gut ammonium production in the fasting dog. Gastroenterology. 1979;77:235-40. [PMID: 447037]
5. Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718-23. [PMID: 11569701]
6. Taylor L, Liu X, Newsome W, Shapiro RA, Srinivasan M, Curthoys NP. Isolation and characterization of the promoter region of the rat kidney-type glutaminase gene. Biochim Biophys Acta. 2001;1518:132-6. [PMID: 11267668]
7. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 1998;28:45-9. [PMID: 9657095]
8. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology. 2004;39:739-45. [PMID: 14999692]
9. Romero-Gómez M, Ramos-Guerrero R, Grande L, de Terán LC, Corpas R, Camacho I, et al. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol. 2004;41:49-54. [PMID: 15246207]
10. Romero-Gómez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology. 2004;39:939-43. [PMID: 15057897]
11. Vergara-Gómez M, Flavià-Olivella M, Gil-Prades M, Dalmau-Obrador B, Córdoba-Cardona J. [Diagnosis and treatment of hepatic encephalopathy in Spain: results of a survey of hepatologists]. Gastroenterol Hepatol. 2006;29:1-6. [PMID: 16393622]
12. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768-73. [PMID: 11434627]
13. Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007;45:879-85. [PMID: 17393525]
14. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846-52. [PMID: 11097497]
15. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23:164-76. [PMID: 8550036]
16. Rimola A, García-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol. 2000;32:142-53. [PMID: 10673079]
17. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics. 1997;53:1253-61. [PMID: 9423247]
18. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet. 2004;68:165-77. [PMID: 15008795]
19. Strachan T, Read AP, eds. Human Molecular Genetics. Oxford: Bios Scientific; 1996:266-7.
20. Chen R, Morgan AA, Dudley J, Deshpande T, Li L, Kodama K, et al. FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease. Genome Biol. 2008;9:R170. [PMID: 19061490]
21. Campos J, Gonzalez-Quintela A, Quinteiro C, Gude F, Perez LF, Torre JA, et al. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol Clin Exp Res. 2005;29:1206-13. [PMID: 16046876]
22. Bernal W, Donaldson P, Underhill J, Wendon J, Williams R. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. J Hepatol. 1998;29:53-9. [PMID: 9696492]
23. Zhang B, Yuan Y, Jia Y, Yu X, Xu Q, Shen Y, et al. An association study between polymorphisms in five genes in glutamate and GABA pathway and paranoid schizophrenia. Eur Psychiatry. 2005;20:45-9. [PMID: 15642443]
24. Romero-Gómez M. Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy. Metab Brain Dis. 2005;20:319-25. [PMID: 16382342]
25. Labow BI, Souba WW, Abcouwer SF. Mechanisms governing the expression of the enzymes of glutamine metabolism - glutaminase and glutamine synthetase. J Nutr. 2001;131:2467S-74S. [PMID: 11533295]
26. Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr. 1995;15:133-59. [PMID: 8527215]
27. Mock B, Kozak C, Seldin MF, Ruff N, D'Hoostelaere L, Szpirer C, et al. A glutaminase (gis) gene maps to mouse chromosome 1, rat chromosome 9, and human chromosome 2. Genomics. 1989;5:291-7. [PMID: 2571577]
28. Hwang JJ, Perera S, Shapiro RA, Curthoys NP. Mechanism of altered renal glutaminase gene expression in response to chronic acidosis. Biochemistry. 1991;30:7522-6. [PMID: 1854751]
29. Erdmann N, Tian C, Huang Y, Zhao J, Herek S, Curthoys N, et al. In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1- infected macrophage. J Neurochem. 2009;109:551-61. [PMID: 19222703]
30. Iglesias AR, Kindlund E, Tammi M, Wadelius C. Some microsatellites may act as novel polymorphic cis-regulatory elements through transcription factor binding. Gene. 2004;341:149-65. [PMID: 15474298]
31. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458:762-5. [PMID: 19219026]
32. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008;40:43-50. [PMID: 18066065]
33. Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology. 2006;44:788-94. [PMID: 17006913]